Search Results

There are 7477 results for: content related to: The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey

  1. Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 10, October 2013, Pages: 1086–1092, Mira Harrison-Woolrych, Helen Paterson and Ming Tan

    Article first published online : 8 AUG 2013, DOI: 10.1002/pds.3489

  2. Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 11, November 2014, Pages: 1205–1212, David J. Graham, Kunthel By, Stephen McKean, Andrew Mosholder, Cynthia Kornegay, Judith A. Racoosin, Jessica Young, Mark Levenson, Thomas E. MaCurdy, Chris Worrall and Jeffrey A. Kelman

    Article first published online : 5 JUL 2014, DOI: 10.1002/pds.3678

  3. Commentary on “The Effectiveness of Varenicline Medication Guide for Conveying Safety Information to Patients: a REMS Assessment Survey” by Enger et al.

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 7, July 2013, Pages: 716–718, Gerald J. Dal Pan

    Article first published online : 9 MAY 2013, DOI: 10.1002/pds.3450

  4. You have free access to this content
    Nicotine receptor partial agonists for smoking cessation

    Intervention Review

    The Cochrane Library

    Kate Cahill, Lindsay F Stead and Tim Lancaster

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD006103.pub6

  5. You have free access to this content
    Pharmacological interventions for smoking cessation: an overview and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Kate Cahill, Sarah Stevens, Rafael Perera and Tim Lancaster

    Published Online : 31 MAY 2013, DOI: 10.1002/14651858.CD009329.pub2

  6. You have full text access to this OnlineOpen article
    Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens

    British Journal of Pharmacology

    Volume 171, Issue 14, July 2014, Pages: 3420–3431, A A Feduccia, J A Simms, D Mill, H Y Yi and S E Bartlett

    Article first published online : 25 JUN 2014, DOI: 10.1111/bph.12690

  7. The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats

    Addiction Biology

    Volume 20, Issue 2, March 2015, Pages: 248–258, Wouter Goutier, Margreet B. Kloeze and Andrew C. McCreary

    Article first published online : 20 NOV 2013, DOI: 10.1111/adb.12108

  8. Effects of Varenicline on Ethanol-Induced Conditioned Place Preference, Locomotor Stimulation, and Sensitization

    Alcoholism: Clinical and Experimental Research

    Volume 38, Issue 12, December 2014, Pages: 3033–3042, Noah R. Gubner, Carrie S. McKinnon and Tamara J. Phillips

    Article first published online : 7 JAN 2015, DOI: 10.1111/acer.12588

  9. Safety information in drug labeling: a comparison of the USA, the UK, and Japan

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 3, March 2013, Pages: 306–318, Rumiko Shimazawa and Masayuki Ikeda

    Article first published online : 28 JAN 2013, DOI: 10.1002/pds.3408

  10. Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy

    Addiction

    Volume 108, Issue 8, August 2013, Pages: 1497–1502, Eva Kralikova, Alexandra Kmetova, Lenka Stepankova, Kamila Zvolska, Rachel Davis and Robert West

    Article first published online : 13 MAY 2013, DOI: 10.1111/add.12219

  11. Pharmacokinetics, Safety, and Tolerability Following Multiple Oral Doses of Varenicline Under Various Titration Schedules in Elderly Nonsmokers

    The Journal of Clinical Pharmacology

    Volume 51, Issue 4, April 2011, Pages: 492–501, Dr Qinying Zhao, Dr Elias Schwam, Dr Terence Fullerton, Ms Melissa O'Gorman and Dr Aaron H. Burstein

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010370461

  12. Multiple-Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Smokers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 12, December 2006, Pages: 1439–1448, Dr Hélène M. Faessel, Dr Megan A. Gibbs, Dr David J. Clark, Mr Kevin Rohrbacher, Dr Marilyn Stolar and Dr Aaron H. Burstein

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006292624

  13. AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology

    British Journal of Pharmacology

    Volume 172, Issue 7, April 2015, Pages: 1834–1845, Andrea Cippitelli, Jinhua Wu, Kelly A Gaiolini, Daniela Mercatelli, Jennifer Schoch, Michelle Gorman, Alejandra Ramirez, Roberto Ciccocioppo, Taline V Khroyan, Dennis Yasuda, Nurulain T Zaveri, Conrado Pascual, Xinmin (Simon) Xie and Lawrence Toll

    Article first published online : 23 JAN 2015, DOI: 10.1111/bph.13034

  14. Effect of Human Renal Cationic Transporter Inhibition on the Pharmacokinetics of Varenicline, a New Therapy for Smoking Cessation: An In VitroIn Vivo Study

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 4, April 2008, Pages: 567–576, B Feng, RS Obach, AH Burstein, DJ Clark, SM de Morais and HM Faessel

    Article first published online : 31 OCT 2007, DOI: 10.1038/sj.clpt.6100405

  15. The Nicotinic Acetylcholine Receptor Partial Agonist Varenicline Increases the Ataxic and Sedative-Hypnotic Effects of Acute Ethanol Administration in C57BL/6J Mice

    Alcoholism: Clinical and Experimental Research

    Volume 34, Issue 12, December 2010, Pages: 2053–2060, Helen M. Kamens, Jimena Andersen and Marina R. Picciotto

    Article first published online : 14 OCT 2010, DOI: 10.1111/j.1530-0277.2010.01301.x

  16. Pharmacokinetics, Safety, and Tolerability After Single and Multiple Oral Doses of Varenicline in Elderly Smokers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 11, November 2006, Pages: 1234–1240, Dr Aaron H. Burstein, Dr Terence Fullerton, Dr David J. Clark and Dr Hélène M. Faessel

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006291837

  17. Single-Dose Pharmacokinetics of Varenicline, a Selective Nicotinic Receptor Partial Agonist, in Healthy Smokers and Nonsmokers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 9, September 2006, Pages: 991–998, Dr Hélène M. Faessel, Dr Bill J. Smith, Dr Megan A. Gibbs, Dr Jason S. Gobey, Dr David J. Clark and Dr Aaron H. Burstein

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006290669

  18. Varenicline in the routine treatment of tobacco dependence: a pre–post comparison with nicotine replacement therapy and an evaluation in those with mental illness

    Addiction

    Volume 103, Issue 1, January 2008, Pages: 146–154, John A. Stapleton, Lucy Watson, Lucy I. Spirling, Robert Smith, Andrea Milbrandt, Marina Ratcliffe and Gay Sutherland

    Article first published online : 19 NOV 2007, DOI: 10.1111/j.1360-0443.2007.02083.x

  19. Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial

    Addiction

    Volume 109, Issue 9, September 2014, Pages: 1554–1563, Shadi Nahvi, Yuming Ning, Kate S. Segal, Kimber P. Richter and Julia H. Arnsten

    Article first published online : 27 JUN 2014, DOI: 10.1111/add.12631

  20. Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 4, April 2008, Pages: 607–614, SL McColl, AH Burstein, KR Reeves, CB Billing Jr, M Stolar and EM Sellers

    Article first published online : 20 FEB 2008, DOI: 10.1038/sj.clpt.6100510